We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App





KaiMi Biotech Highlights First of Its Kind Color-Changing Swabs

By LabMedica International staff writers
Posted on 13 Nov 2023

KaiMi Biotech (Jiangsu, China) is highlighting its innovative Unow multiplexing drug tests and first-of-its-kind QiDix color-changing swabs at MEDICA 2023. More...

KaiMi Biotech has launched a series of breakthrough Unow multiplexing drug tests based on its proprietary user-friendly Unow technology platform. These innovative drug tests offer several unprecedented advantages over existing drug tests available in the market to meet the long unmet needs of users. The tests need only a small quantity of saliva sample (80 ml) and a short sampling time (2s) to provide user convenience. A color-appearing indicator tells users if enough saliva has been collected to give them confidence and prevent test inconsistency as a result of sampling errors.

The Unow multiplexing drug tests can be run by a single hand with fewer steps than existing commercial tests and the results can be obtained in 5-10 minutes. Integrated running buffers in the test devices eliminate direct user contact with liquid diluent and reduce potential contamination. The US FDA-approved and CE-marked tests offer excellent detection sensitivity for all the common drugs of abuse that meets the standard cutoffs for most regions around the world. The tests offer great flexibility for customization for detecting different combinations of drugs in a single device to meet the customer’s specific needs.

At MEDICA 2023, KaiMi is also presenting its flagship product, the QiDix color-changing swabs. These swabs are immobilized with a proprietary color indicator to help users ensure that enough samples have been collected. The US FDA-approved QiDix swabs are particularly useful for collecting samples for babies and kids, or patients who have challenges collecting samples by themselves. The indicator can be triggered by body fluids such as saliva, nasal secretion, sweat, tears, and urine, but not by water. The color change will not fade once triggered and the color indicators consist of only safe food-grade ingredients. A number of types of QiDix swabs are available, ranging from flocked swabs, woven swabs, and cotton swabs.

Related Links:
KaiMi Biotech


New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Ultra-Low Temperature Freezer
iUF118-GX
New
Calprotectin Assay
Fecal Calprotectin ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.